Your browser doesn't support javascript.
loading
CorrespondenceMetastatic basal cell carcinoma with neuroendocrine differentiation: complete response to cemiplimab.
Marti-Marti, Ignasi; Puig, Susana; Albero-González, Raquel; Masferrer, Emili; Iglesias, Pablo; Pérez-Anker, Javiera; Serra-García, Laura; Tarroch, Xavier; Curcó, Neus; Toll, Agustí.
Affiliation
  • Marti-Marti I; Dermatology Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
  • Puig S; Dermatology Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
  • Albero-González R; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Masferrer E; Centro de Investigación en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain.
  • Iglesias P; Pathology Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
  • Pérez-Anker J; Department of Dermatology, Hospital Universitari Mútua Terrassa, Barcelona, Spain.
  • Serra-García L; Dermatology Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
  • Tarroch X; Dermatology Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
  • Curcó N; Dermatology Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
  • Toll A; Department of Pathology, Hospital Universitari Mútua Terrassa, Barcelona, Spain.
Clin Exp Dermatol ; 49(9): 1060-1062, 2024 Aug 22.
Article in En | MEDLINE | ID: mdl-38494790

Full text: 1 Database: MEDLINE Main subject: Skin Neoplasms / Carcinoma, Basal Cell / Antibodies, Monoclonal, Humanized Limits: Aged / Female / Humans / Male Language: En Year: 2024 Type: Article

Full text: 1 Database: MEDLINE Main subject: Skin Neoplasms / Carcinoma, Basal Cell / Antibodies, Monoclonal, Humanized Limits: Aged / Female / Humans / Male Language: En Year: 2024 Type: Article